RIL
IMVT icon

Rothschild Investment LLC’s Immunovant IMVT Stock Holding History

Rothschild Investment LLC’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.71K Buy
109
+23
+27% +$595 ﹤0.01% 2400
2025
Q4 		$2.19K Buy
86
+31
+56% +$691 ﹤0.01% 2320
2025
Q3 		$887 Sell
55
-105
-66% -$1.7K ﹤0.01% 2637
2025
Q2 		$2.56K Buy
160
+110
+220% +$1.66K ﹤0.01% 1893
2025
Q1 		$855 Sell
50
-5
-9% -$105 ﹤0.01% 2422
2024
Q4 		$1.36K Sell
55
-5
-8% -$142 ﹤0.01% 2035
2024
Q3 		$1.71K Buy
60
+35
+140% +$1.03K ﹤0.01% 1808
2024
Q2 		$660 Buy
25
+20
+400% +$569 ﹤0.01% 1863
2024
Q1 		$162 Buy
+5
New +$182 ﹤0.01% 1855

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Rothschild Investment LLC's IMVT Position: Q1 2026 in Review

Rothschild Investment LLC increased its Immunovant (IMVT) stake by 27% in Q1 2026, buying an estimated $595 and bringing the position to 109 shares worth $2.71K. The position accounts for ﹤0.01% of the portfolio, ranked #2400.

Rothschild Investment LLC first reported a position in IMVT in Q1 2024 and has held it in 9 quarters since. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Rothschild Investment LLC held 109 shares of Immunovant worth $2.71K as of Q1 2026.
  • Rothschild Investment LLC bought 23 Immunovant shares in Q1 2026, an estimated $595.
  • Immunovant made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #2400 holding.
  • Rothschild Investment LLC first reported a position in Immunovant in Q1 2024 and has held it in 9 quarters since.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.